Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...

December 4, 2025 – Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Refresh your defensive driving skills this holiday season with ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...

1. What are the risk factors for bladder cancer? Smoking is the biggest risk factor, responsible for about half of all cases. risk over time. Drink plenty of fluidsespecially water. Staying ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

Adding Bladder EpiCheck® to surveillance cystoscopies in high-risk non-muscle invasive bladder cancer (NMIBC) patients increased the detection of High-Grade recurrences by 65% Bladder EpiCheck detects ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...

NEW YORK – Backed by recently published study results, South Korean molecular diagnostic test developer Genomictree aims to soon secure regulatory approval in South Korea for its noninvasive bladder ...